A series of aminobenzimidazole-substituted pyrimidines were synthesized and evaluated for biochemical activity against CDK1. A high-speed parallel synthesis approach enabled the identification of a potent lead series having improved potency in the CDK1 assay (IC(50)<10nM). Cell cycle analysis showed that the compounds induced a G2/M block. Docking studies were carried out with a CDK1 homology model, and provide a rationale for the observed activities.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/j.bmcl.2005.02.076 | DOI Listing |
Publication Analysis
Top Keywords
substituted aminobenzimidazole
4
aminobenzimidazole pyrimidines
4
pyrimidines cyclin-dependent
4
cyclin-dependent kinase
4
kinase inhibitors
4
inhibitors series
4
series aminobenzimidazole-substituted
4
aminobenzimidazole-substituted pyrimidines
4
pyrimidines synthesized
4
synthesized evaluated
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!